Correlation Between Larimar Therapeutics and Incyte
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Incyte, you can compare the effects of market volatilities on Larimar Therapeutics and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Incyte.
Diversification Opportunities for Larimar Therapeutics and Incyte
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Larimar and Incyte is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Incyte go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Incyte
Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 1.71 times less return on investment than Incyte. In addition to that, Larimar Therapeutics is 2.73 times more volatile than Incyte. It trades about 0.05 of its total potential returns per unit of risk. Incyte is currently generating about 0.24 per unit of volatility. If you would invest 6,907 in Incyte on November 1, 2024 and sell it today you would earn a total of 465.00 from holding Incyte or generate 6.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. Incyte
Performance |
| Timeline |
| Larimar Therapeutics |
| Incyte |
Larimar Therapeutics and Incyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and Incyte
The main advantage of trading using opposite Larimar Therapeutics and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |